These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 6468826

  • 1. [Treatment of chronic active HBsAg-positive hepatitis with thymostimulin].
    Nardiello S, Russo M, Pizzella T, Galanti B, Giusti G.
    G Ital Chemioter; 1984; 31(1-2):181-4. PubMed ID: 6468826
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment with thymic extract TFX for chronic active hepatitis B.
    Dworniak D, Tchórzewski H, Pokoca L, Tkacz B, Drobnik S, Baj Z, Luciak M.
    Arch Immunol Ther Exp (Warsz); 1991; 39(5-6):537-47. PubMed ID: 1841551
    [Abstract] [Full Text] [Related]

  • 6. [Thymostimulin in chronic hepatitis B virus infection].
    Mas A, Bruguera M, Costa J, Sánchez Tapias JM.
    Med Clin (Barc); 1987 Sep 26; 89(9):398-9. PubMed ID: 3669798
    [No Abstract] [Full Text] [Related]

  • 7. [Effects of a treatment with a thymus extract (thymostimulin) in acute viral hepatitis B in drug-dependent patients].
    Corridori S, Trespi G, Baldini E, Renzetti I, Calderon W.
    Boll Ist Sieroter Milan; 1984 Sep 26; 63(6):519-28. PubMed ID: 6242017
    [Abstract] [Full Text] [Related]

  • 8. [Immunotherapy of chronic active hepatitis (HBsAg+) with calf thymus extract (TFX-Polfa). Clinical evaluation].
    Cianciara J, Babiuch L, Górska E, Kassur B.
    Pol Tyg Lek; 1984 Aug 13; 39(33):1097-101. PubMed ID: 6390376
    [No Abstract] [Full Text] [Related]

  • 9. [Immunomodulating drugs, thymalin and T-activin in the treatment of chronic liver diseases].
    Iakhontova OI, Dudanova OP, Khavinson VKh.
    Sov Med; 1990 Aug 13; (6):85-8. PubMed ID: 2396134
    [No Abstract] [Full Text] [Related]

  • 10. [Preliminary evaluation of the results of treatment of chronic active hepatitis (HBsAg+) with calf thymus extract (TFX-Polfa)].
    Juszczyk J.
    Pol Tyg Lek; 1984 Aug 13; 39(33):1085-9. PubMed ID: 6504737
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Course of chronic virus hepatitis B in children and attempts at modifying its treatment].
    Kowalik-Mikołajewska B.
    Pol Tyg Lek; 1984 Aug 13; 48(11-13):258-60. PubMed ID: 7694262
    [Abstract] [Full Text] [Related]

  • 14. Antiviral therapy in HBsAg-positive chronic liver disease (HBsAg+ve CLD): how many patients really need it?
    Ascione A, Amitrano L, Riccio E, De Lella A, Canestrini C, de Bellis G, D'Alessandro R, Fiore R, Padulano P.
    Hepatogastroenterology; 1984 Jun 13; 31(3):123-4. PubMed ID: 6469200
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Antiviral therapy of HBsAg positive chronic hepatitis: progress or erroneous development?].
    Hess G.
    Med Klin (Munich); 1987 May 15; 82(11):419-20. PubMed ID: 3600545
    [No Abstract] [Full Text] [Related]

  • 18. [Long-term results of treatment of chronic active hepatitis B with vidarabine monophosphate].
    Causse X, Guérou V, Rougier P, Trépo C.
    Gastroenterol Clin Biol; 1993 May 15; 17(2):144-5. PubMed ID: 7684714
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Immunosuppressive treatment of patients with chronic active HBsAg positive hepatitis].
    Tanno H, Fay O, Roldán L, Vorovioff J.
    Acta Gastroenterol Latinoam; 1982 May 15; 12(4):323-32. PubMed ID: 7185230
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.